Skip to main content

Drug utilization review educational bulletins

November 2023


2023 Immunization Update: COVID-19, Influenza, RSV, HepB, Pneumococcal, HPV, Polio, Mpox, and MMR


August 2023


No Added Benefit from Concomitant Use of GLP-1 Agonists and DPP-4 Inhibitors (PDF)


New Resources Available for Perinatal Mental Health Conditions (PDF)


June 2023


FDA Approves First Over-the-Counter Naloxone Nasal Spray (PDF)


Updated Guidance by the CDC and FDA for Prescribing Opioids (PDF)


May 2023


Clinical Review: Management of Acute Postpartum Pain (PDF)


January 2023


2022 Immunization Update: Mpox, HepB, Influenza, COVID-19, Pneumococcal, Zoster (PDF)


Improving the Quality of Care: Treatment of Latent Tuberculosis Infection (PDF)


Risks to Patients Exposed to Xylazine in Illicit Drugs (PDF)


Removal of DATA-Waiver (X-Waiver) Requirement (PDF)


May 2022


Submitting Quality Data to the California Immunization Registry (CAIR2) (PDF)


March 2022


Improving the Quality of Care: Legislative Impact on the Use of Naloxone (PDF)


February 2022


Professional Organizations Push for Recall of Buprenorphine Dental Warning (PDF)


September 2021


UPDATED: Drug Safety Communication: Voluntary Recall of Varenicline (Chantix) Due to Nitrosamine (PDF)

2021 Immunization Updates: COVID-19, Influenza, and Meningococcal Disease (PDF)


August 2021


Drug Safety Communication: FDA Requests Removal of Pregnancy Contraindication for Statins (PDF)


April 2021


Drug Safety Communication: Potential Increased Arrhythmia Risk from Lamotrigine (PDF)


March 2021


Clinical Review: Recommendations for the Tapering of Benzodiazepines (PDF)


January 2021


Clinical Review: Recommendations for the Management of Acute Dental Pain (PDF)


August 2020


Clinical Review: 2020 Standards of Care for Treatment of Type 2 Diabetes (PDF)


August 2019


CDC, ACIP release flu vaccine recommendations for upcoming flu season (PDF)


CDC, ACIP release human papillomavirus vaccination for adults: updated recommendations (PDF)



July 2019


CDC releases interim infection prevention and control recommendations for measles


California drug take-back program

Accelerating opioid safety: ambulatory care toolkit (PDF)



July 2018


Drug safety communication: adverse effects from fluoroquinolone antibiotics (PDF)



March 2018


In the pharmacy: pharmacists furnishing nicotine replacement products (PDF)



February 2018


Drug safety communication: new age limit for opioid cough and cold medicines (PDF)



September 2017


Alert: online report to the Vaccine Adverse Event Reporting System (VAERS) (PDF)

2017 immunization updates: influenza, HepA, meningococcal, HPV, adult vaccines (PDF)

Also of interest: